Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Operating Leases (2022 - 2025)

Treace Medical Concepts' Operating Leases history spans 4 years, with the latest figure at $14.0 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 12.25% year-over-year to $14.0 million; the TTM value through Dec 2025 reached $14.0 million, down 12.25%, while the annual FY2025 figure was $14.0 million, 12.25% down from the prior year.
  • Operating Leases reached $14.0 million in Q4 2025 per TMCI's latest filing, up from $12.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $19.0 million in Q3 2022 to a low of $12.9 million in Q3 2025.
  • Average Operating Leases over 4 years is $15.7 million, with a median of $15.9 million recorded in 2023.
  • Peak YoY movement for Operating Leases: rose 4.65% in 2024, then decreased 21.57% in 2025.
  • A 4-year view of Operating Leases shows it stood at $15.5 million in 2022, then rose by 2.27% to $15.9 million in 2023, then increased by 0.27% to $15.9 million in 2024, then fell by 12.25% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Operating Leases are $14.0 million (Q4 2025), $12.9 million (Q3 2025), and $13.4 million (Q2 2025).